AU Patent

AU2011255633B2 — Methods of treating recurring bacterial infection

Assigned to Merck Sharp and Dohme LLC · Expires 2014-09-11 · 12y expired

What this patent protects

The present invention relates to methods of treating a recurring gastrointestinal (Gl) infection of Clostridium difficile in a subject comprising administering to the subject an effective amount of the compounds of the present invention.

USPTO Abstract

The present invention relates to methods of treating a recurring gastrointestinal (Gl) infection of Clostridium difficile in a subject comprising administering to the subject an effective amount of the compounds of the present invention.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011255633B2
Jurisdiction
AU
Classification
—
Expires
2014-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.